FDA
label_change
· 2018-06-27
FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
Summary
FDA approved a supplemental application for levocetirizine dihydrochloride (Glenmark Pharmaceuticals Inc., USA) under the ANDA process, leading to labeling upda…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for LEVOCETIRIZINE DIHYDROCHLORIDE (LEVOCETIRIZINE DIHYDROCHLORIDE)